Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701478-24-000012
Filing Date
2024-11-12
Accepted
2024-11-12 17:01:49
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aztr-20240930.htm   iXBRL 10-Q 1092779
2 EX-31.1 aztr-20240930xexx311.htm EX-31.1 10143
3 EX-31.2 aztr-20240930xexx312.htm EX-31.2 10313
4 EX-32.1 aztr-20240930xexx321.htm EX-32.1 7092
10 GRAPHIC aztr-20240930_g1.jpg GRAPHIC 118776
  Complete submission text file 0001701478-24-000012.txt   6622365

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aztr-20240930.xsd EX-101.SCH 51157
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aztr-20240930_cal.xml EX-101.CAL 70949
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aztr-20240930_def.xml EX-101.DEF 252579
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aztr-20240930_lab.xml EX-101.LAB 584346
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aztr-20240930_pre.xml EX-101.PRE 415741
77 EXTRACTED XBRL INSTANCE DOCUMENT aztr-20240930_htm.xml XML 726003
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41705 | Film No.: 241449636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)